PCOS Treatment | PCOS Challenge: The National Polycystic Ovary Syndrome Association

PCOS Challenge to Host Major Patient-Focused Drug Development Meeting

To address critical treatment gaps for polycystic ovary syndrome, PCOS Challenge has organized the PCOS EL-PFDD Meeting for the FDA and medical product developers to hear patients’ experiences and priorities for new treatments.

PCOS Challenge Responds to Global Renaming of Polycystic Ovary Syndrome

An announcement was made today to change the name of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). For many in the PCOS community, this change is complicated.